Regulations on the Supervision and Administration of Medical Devices
Effective June 1, 2021The cornerstone regulation: registrant (legal agent) system, risk-based classification and full lifecycle oversight.
Master FrameworkChina medical device regulations and NMPA regulatory updates — tracked continuously and interpreted with submission practice in mind.
The core documents shaping China's medical device regulatory framework — the regulatory baseline every overseas manufacturer should know.
The cornerstone regulation: registrant (legal agent) system, risk-based classification and full lifecycle oversight.
Master FrameworkCore procedural rules for device registration and filing: dossiers, review, changes and renewals.
RegistrationThe dedicated registration and filing route for in vitro diagnostic reagents, alongside the device measures.
IVDProduction licensing, commissioned manufacturing and cross-region oversight requirements.
ManufacturingDistribution licensing, incoming inspection and trading compliance requirements.
Distribution22 sub-catalogues defining device classes — the starting point for filing vs. registration pathways.
ClassificationAmendments, announcements and new guidance — tracked here with practical implications for overseas manufacturers. Click any article to read the full text.
The complete pathway for foreign manufacturers: classification, agent, dossier, testing, clinical evaluation, statutory timelines and costs.
Legal basis of the in-country representative, how it differs from distributors and EU authorized reps, and how to switch agents safely.
Choose the fastest defensible evidence route: exemption catalogue, same-variety evaluation, trials and foreign data.
Import rules, roles (agent vs distributor vs importer), special pathways and a ten-step entry roadmap.
Core obligations of overseas registrants, China legal agents and post-market duties under the revised Regulations.
How the catalogue is updated, and what adjustments mean for products already on or entering the market.
Implementation batches, product scope and a step-by-step checklist for overseas manufacturers.
The latest NMPA announcements, classification determinations and guidance — with impact notes for exporters.
Ongoing duties, vigilance reporting timelines and recall coordination — in practical terms.
Pathways, dossier preparation and common questions — based on our hands-on registration coordination.
Regulation Library Browse all articles and past updates — continuously maintainedA few key moments that shaped China's medical device regulatory framework.
The National Medical Products Administration inaugurated, unifying drug and device regulation.
The revised Regulations (State Council Decree No. 739) take effect; the registrant system fully implemented.
Measures for Registration & Filing (Orders No. 47 & 48) take effect on the same day.
Production (No. 53) and distribution (No. 54) measures complete the regulatory chain.
NMPA announcements, guidance and standards — tracked on this page, updated continuously.
Beyond updates, we'd be glad to discuss your product and your route into the Chinese market.